cancer
The latest news on cancer
In trial, ganetespib extended survival for people with a very common form of the disease
Lambrolizumab activates body's immune system to kill cancerous cells, researchers say
Sorafenib appeared to delay disease progression, shrink tumors in early study
10 years on the drug did increase side effects, but survival gains may be worth it, researchers say
Women who got the drug plus standard chemo lived about 4 months longer on average
In preliminary trial, nivolumab shrank tumors in 30 percent of tough-to-treat patients
Study found it prolonged remission after chemotherapy almost six months longer than a placebo
Thought you knew how to use blueberries, peaches and cherries? Think again.
A little 'short-term hassle' may have prevented stage 2 cancer, Wisconsin resident says
Though new techniques are on the horizon, doctors say colon-cleansing is here to stay
